Literature DB >> 6218647

Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.

J A Hughes, M J Tobin, D Bellamy, D C Hutchison.   

Abstract

In patients with radiological evidence of pulmonary emphysema the bronchodilator drugs fenoterol and ipratropium bromide produced a considerable increase in vital capacity and reduction in residual volume. The response to fenoterol was virtually complete 15 minutes after administration, but after ipratropium bromide vital capacity was still increasing at 60 minutes. The change in vital capacity was slightly greater with a combination of the two drugs than with either used alone. Changes in FEV1 and peak flow rate were small.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218647      PMCID: PMC459403          DOI: 10.1136/thx.37.9.667

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Assessment of a combination of doses of fenoterol and ipratropium suitable for a single metered-dose aerosol.

Authors:  G J Addis; J Barclay; E M Chang
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

2.  Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation.

Authors:  G E Marlin; N Berend; A C Harrison
Journal:  Aust N Z J Med       Date:  1979-10

3.  Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.

Authors:  G R Petrie; K N Palmer
Journal:  Br Med J       Date:  1975-02-22

4.  Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.

Authors:  H Poppius; Y Salorinne
Journal:  Br Med J       Date:  1973-10-20

5.  Bronchodilatation and the site of airway resistance in severe chronic bronchitis.

Authors:  N J Douglas; I Davidson; M F Sudlow; D C Flenley
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

6.  Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis.

Authors:  I M Lightbody; C G Ingram; J S Legge; R N Johnston
Journal:  Br J Dis Chest       Date:  1978-07

7.  The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema.

Authors:  D Bellamy; D C Hutchison
Journal:  Br J Dis Chest       Date:  1981-04
  7 in total
  9 in total

Review 1.  Management of chronic obstructive pulmonary disease.

Authors:  S Kesten; A S Rebuck
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 2.  Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; T Izumi
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

3.  Changes in transcutaneous oxygen tension during exercise in pulmonary emphysema.

Authors:  J A Hughes; B J Gray; D C Hutchison
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

Review 4.  Chronic obstructive pulmonary disease.

Authors:  N R Anthonisen
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262

5.  Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.

Authors:  K Nishi; M Fujimura; S Myou; T Ooka; S Sakamoto; M Saitou; K Kasahara; T Matsuda
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

6.  Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.

Authors:  P Moayyedi; J Congleton; R L Page; S B Pearson; M F Muers
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

Review 7.  Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?

Authors:  Chakravarthy B Reddy; Richard E Kanner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Comparison of one versus two bronchodilators in ventilated COPD patients.

Authors:  A Fernandez; J Muñoz; B de la Calle; I Alia; A Ezpeleta; M A de la Cal; A Reyes
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

9.  Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; H Koyama; T Izumi
Journal:  Thorax       Date:  1995-01       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.